Utilidad clínica Cistatina C en el diagnóstico temprano de la disfunción renal en pacientes con Diabetes Mellitus Tipo 2
DOI:
https://doi.org/10.56048/MQR20225.8.1.2024.2593-2616Palabras clave:
Biomarcadores; Disfunción renal; Nefropatía; Parámetros; SensibilidadResumen
La Diabetes Mellitus Tipo 2 es una preocupación global con creciente prevalencia, especialmente en naciones como China e India. Los pacientes diabéticos enfrentan el riesgo de desarrollar enfermedad renal diabética, una complicación costosa y asintomática durante largos periodos. Se llevó a cabo un estudio de tipo documental, descriptivo con el objetivo de destacar la utilidad clínica de la Cistatina C en el diagnóstico temprano de la disfunción renal en pacientes diabéticos. En los resultados, la variabilidad en los valores de referencia para la cistatina C demostró su sensibilidad en la detección temprana de nefropatía diabética. La evaluación de la función renal en pacientes diabéticos requiere considerar múltiples parámetros. La Cistatina C, aunque limitada en especificidad, mostró cambios tempranos y sensibilidad en la identificación de alteraciones en la función renal. Su combinación con otros biomarcadores mejoró la precisión diagnóstica. Se destacó la sensibilidad única de la Cistatina C en la detección temprana de la nefropatía diabética, identificando grupos de pacientes con alteraciones en la función renal antes que los marcadores tradicionales. En conclusión, la adopción de un enfoque integral que incorpore la Cistatina C en conjunto con otros marcadores destaca la imperante necesidad de implementar una estrategia diagnóstica más exhaustiva y específica en la gestión clínica de pacientes diabéticos.
Descargas
Métricas
Cited
DOI: 10.56048
Citas
Akpınar, K., Aslan, D., & Fenkçi, S. M. (2021). Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy. J Bras Nefrol, 43(3), 340–348. https://doi.org/10.1590/2175-8239-JBN-2020-0145
Ali , M., Bullard , K. M., Saydah , S., Imperatore , G., & Gregg , E. W. (2018). Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014. Lancet Diabetes Endocrinol, 6(5), 392-403. https://doi.org/10.1016/S2213-8587(18)30027-5
ALkhader, R. A., Elias, N. G., Lateef, A. S., Alkubaisi, M. R., & AlAbdaly, A. R. (2022). Estimation of cystatin C and inflammation marker levels in type 2 diabetes mellitus patients with microalbuminuria. Journal of Emergency Medicine, Trauma & Acute Care, 2022(6), 16. https://doi.org/https://doi.org/10.5339/jemtac.2022.aimco.16
Al-Nasrawii, M. S., Jasim, B. S., & Hassan, S. H. (2020). A comparative assessment of serum creatinine and cystatin c as a significance of nephropathy in diabetic patients. Malaysian Journal of Public Health Medicine, 20(3), 189-194. https://doi.org/https://doi.org/10.37268/mjphm/vol.20/no.3/art.527
ALsailawi, H. A., Mudhafar, M., Majhool, A. A., & Asaad, A. (2019). Study of Cystatin C as early biomarker of nephropathy in patients with type 2 DM and risk stratification in Tarnaka Hospital of Hyderabad City in India. Journal of US-China Medical Science, 16, 232-41. https://doi.org/10.17265/1548-6648/2019.05.004
Amelia, R., Sari, D. K., Muzasti, R. A., & Wijaya, H. (2022). Correlation of Cystatin-c with Albumin Creatinine Ratio for the Diagnosis of Diabetic Nephropathy in Patients with Type 2 Diabetes: A Cross-sectional Study in Medan Indonesia. Open Access Macedonian Journal of Medical Sciences, 10(T7), 12-15. https://doi.org/https://doi.org/10.3889/oamjms.2022.9249
Amin, R., Ahn, S. Y., & Moudgil, A. (2021). Kidney and urinary tract disorders. En D. Dietzen, M. Bennett, E. Wong, & S. Haymond (Edits.), Biochemical and molecular basis of pediatric disease (págs. 167-228). Academic Press. https://doi.org/https://doi.org/10.1016/B978-0-12-817962-8.00010-X
Asmamaw, T., Genet, S., Menon, M., Tarekegn, G., Chekol, E., Geto, Z., Lejisa, T., Habtu, W., Getahun, T., & Tolcha , Y. (2020). Early detection of renal impairment among patients with type 2 diabetes mellitus through evaluation of serum cystatin C in comparison with serum creatinine levels: a cross-sectional study. Diabetes, Metabolic Syndrome and Obesity, 13, 4727–4735. https://doi.org/10.2147/DMSO.S279949
Azim Mohammed, R. A., El-Shazely, A., Haridy, M. A., Abdel Aal, A. M., Mohammad Soliman, M., Sayed Mostafa, K. E., Abdel Aziz, E. M., & Hassan, M. (2019). Diagnostic Values Of Serum Cystatin C And Urinary Fetuin-A As Early Biochemical Markers In Predicting Diabetic Nephropathy Among Patients With Type 2 Diabetes Mellitus. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 10(6), 237-244. https://doi.org/https://doi.org/10.33887/rjpbcs/2019.10.6.29
Batista Garcet, C., Batista Garcet, Y., Jiménez Jiménez, C., & Rodríguez Pincay, R. (2020). Perfil renal como ayuda al diagnóstico en habitantes de la parroquia la américa del Cantón Jipijapa. UNESUM - Ciencias. Revista Científica Multidisciplinaria, 4(3), 141-156. https://doi.org/https://doi.org/10.47230/unesum-ciencias.v5.n5.2021.206
Benavides Couto, A., Rodríguez Jiménez, Y., González Borges, G., Martinez Serrano, I. L., Hernandez Palet, I., & Vilaboy Perez, B. R. (2019). Utilización del biomarcador de cistatina C en pacientes con posible fallo renal. Revista de Enfermedades no Transmisibles Finlay, 9(4), 306-313. https://revfinlay.sld.cu/index.php/finlay/article/view/717
Blanco Naranjo, E. G., Chavarría Campos, G. F., & Garita Fallas, Y. M. (2021). Estilo de vida saludable en diabetes mellitus tipo 2: beneficios en el manejo crónico. Rev.méd.sinerg, 6(2), e639. https://doi.org/https://doi.org/10.31434/rms.v6i2.639
Centers for Disease Control and Prevention. (2020). National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf
Cheng, Y. S., Chao, J., Chen, C., Lv, L. L., Han, Y. C., & Liu, B. C. (2019). The PKCβ-p66shc-NADPH oxidase pathway plays a crucial role in diabetic nephropathy. J Pharm Pharmacol, 71(3), 338-347. https://doi.org/https://doi.org/10.1111/jphp.13043
Cho , N. H., Shaw , J. E., Karuranga , S., Huang , Y., da Rocha Fernandes, J. D., Ohlrogge , A. W., & Malanda , B. (2018). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice, 138, 271-281. https://doi.org/10.1016/j.diabres.2018.02.023
Dejenie, T. A., Abebe, E. C., Mengstie , M. A., Seid , M. A., Gebeyehu, N. A., Adella , G. A., Kassie , G. A., Gebrekidan , A. Y., Gesese, M. M., Tegegne, K. D., Anley , D. T., Feleke, S. F., Zemene, M. A., Dessie, A. M., Moges, N., Kebede, Y. S., Bantie, B., & Adugna , D. G. (2023). Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne), 14, 1124367. https://doi.org/https://doi.org/10.3389/fendo.2023.1124367
Deva, S., & Toshikhane, H. (2020). SIGNIFICANCE OF CYSTATIN-C (SERUM MARKER FINDING) LABORATORY INVESTIGATION IN EARLY RECOGNITION OF RENAL DYSFUNCTION IN DIABETES MELLITUS WITH SPECIAL REFERENCE TO PRAMEHA IN AYURVEDA. International Journal Of Multidisciplinary Educational Research, 9(6), 162-170. https://ijmer.s3.amazonaws.com/pdf/volume9/volume9-issue6(1)-2020.pdf#page=171
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020). Pathophysiology of Type 2 Diabetes Mellitus. Int. J. Mol. Sc, 21(17), 6275. https://doi.org/10.3390/ijms21176275
García Esplugas, D. M., Valdés Castillo, A., Zurita Delgado, F. A., & García Benavides, R. (2018). Cistatina c sérica como marcador de daño renal temprano en sujetos diabéticos tipo 2. Revista Cubana de Investigaciones Biomédicas, 37(4), 0-0. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002018000400006&lng=es&tlng=pt
GBD 2019 Diseases and Injuries Collaborators. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396(10258), 1204-1222. https://doi.org/10.1016/S0140-6736(20)30925-9
GBD 2021 Diabetes Collaborators. (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 402(10397), 203-234. https://doi.org/10.1016/S0140-6736(23)01301-6
Gembillo, G., Ingrasciotta , Y., Crisafulli , S., Luxi , N., Siligato, R., Santoro , D., & Trifirò , G. (2021). Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia. Int J Mol Sci, 22(9), 4824. https://doi.org/10.3390/ijms22094824
Gupta, U. K., Mahajan, M., Gupta, S., Kumar, N., & Gupta, S. (2022). CYSTATIN C AS AN EARLIER MARKER OF NEPHROPATHY IN TYPE 2 DIABETICS OF JAMMU REGION. Group, 1(70), 17-5. https://doi.org/http://dx.doi.org/10.24327/ijrsr.2022.1304.0224
Harding , J. L., Pavkov , M. E., Magliano , D. J., Shaw , J. E., & Gregg , E. W. (2019). Global trends in diabetes complications: a review of current evidence. Diabetologia, 62(1), 3-16. https://doi.org/10.1007/s00125-018-4711-2
Jager , K. J., Kovesdy , C., Langham, R., Rosenberg , M., Jha , V., & Zoccali , C. (2019). A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int, 96(5), 1048-1050. https://doi.org/10.1016/j.kint.2019.07.012
John, A. C., Sreekumari, S., & Varma, S. (2020). Clinical Utility of Serum Cystatin C in Comparison with Serum Creatinine, Urea and Uric Acid in Patients with Chronic Kidney Disease. National Journal of Laboratory Medicine, 9(3), BO06 - BO09. http://www.jcdr.net//back_issues.asp?issn=0973-709x&year=2020&month=July&volume=9&issue=3&page=BO06&id=2397
Kishor, A. K., Sagar, P., & Rai, S. (2020). Serum cystatin C as an early biomarker of chronic kidney disease in diabetic patients. Indian Journal of Basic & Applied Medical Research, 10(1), 237 - 245. https://doi.org/10.36848/IJBAMR/2020/16215.55730
Kovesdy, C. P. (2022). Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011), 12(1), 7-11. https://doi.org/10.1016/j.kisu.2021.11.003
Lambis-Loaiza, L. A., Roldan-Tabares, M. D., & Martínez-Sánchez, L. M. (2022). Enfermedad renal crónica: Cistatina C como marcador diagnóstico. Salutem Scientia Spiritus, 8(3), 51-57. https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/645
Lameire , N. H., Levin , A., Kellum , J. A., Cheung, M., Jadoul , M., Winkelmayer , W. C., & Stevens , P. E. (2021). Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int, 100(3), 516-526. https://doi.org/https://doi.org/10.1016/j.kint.2021.06.028
Lanzhu, P., Langen, Z., Guoxi, J., Po, X., & Mengju, H. (2020). Value of combined detection of serum superoxide dismutases, cystatin C and GHbA1c in the early diagnosis of diabetic nephropathy. JOURNAL OF NEW MEDICINE, 51(9), 687-690. https://doi.org/10.3969/j.issn.0253-9802.2020.09.009
Luo, Y., Wang, Q., Li, H., Lin, W., Yao, J., Zhang, J., Duan, S., Zhang, W., Zheng, Y., Cai, G., Zhang, L., Dong, Z., & Chen, X. (2023). Serum cystatin C is associated with peripheral artery stiffness in patients with type 2 diabetes mellitus combined with chronic kidney disease. Clinical Biochemistry, 118, 110593. https://doi.org/10.1016/j.clinbiochem.2023.110593
Ma, C. C., Duan, C. C., Huang, R. C., & Tang, H. Q. (2020). Association of circulating cystatin C levels with type 2 diabetes mellitus: a systematic review and meta-analysis. Archives of Medical Science, 16(3), 648-656. https://doi.org/https://doi.org/10.5114/aoms.2019.83511
Mahapatra, H. S., Kulshreshtha, B., Goyal , P., Chitkara, A., Kumari, A., Arora, A., Sekhar, V., & Gupta , Y. P. (2022). Comparative diagnostic utility of different urinary biomarkers during pre-albuminuric stages of non-hypertensive type 2 diabetic nephropathy. Indian J Med Res, 156(1), 46-55. https://doi.org/10.4103/ijmr.IJMR_455_21
Mansour, A. E., Abdelmoniem, R. O., Elbadawy, A. M., & Ibrahim, W. M. (2023). The utility of estimation of glomerular filtration rate by serum cystatin C as a predictor of diabetic kidney disease in both type I and type II diabetic patients: a single center study. The Egyptian Journal of Internal Medicine, 35(1), 64. https://doi.org/https://doi.org/10.1186/s43162-023-00243-y
Mercado, M. G., Smith, D. K., & Guard, E. L. (2019). Acute kidney injury: diagnosis and management. American family physician, 100(11), 687-694. https://www.aafp.org/pubs/afp/issues/2019/1201/p687.html
Mucha, A., Amzai, G., Ristevska, T., Milenkovik, T., Jashari, E., Kostadinova, L., Biljali, S., & Jovchevska, J. M. (2020). NGAL and Cystatin C: Two possible early markers of diabetic nephropathy in patients with type 2 diabetes mellitus. Macedonian Medical Review, 74(3), 186-194. http://hdl.handle.net/20.500.12188/11568
Organizacion Mundial de la Salud (OMS). (2022). Diabetes. Retrieved 23 de Agosto de 2023, from Diabetes: https://www.paho.org/es/temas/diabetes
Pallavi, K., Khare, R. L., Patra, P. K., & Rath, D. (2020). Urinary enzymes as early diagnostic marker for diabetic nephropathy: a comparison with cystatin C. International Journal of Science & Healthcare Research, 5(1), 268-273. https://ijshr.com/IJSHR_Vol.5_Issue.1_Jan2020/IJSHR0044.pdf
Pelluri, R., Srikanth, K., Chimakurthy, J., Paritala , H., Yalamanchili, V. K., Prasanna, P. S., & Nagasubramanaian, V. R. (2021). Estimation of Glomerular Filtration Rate and Predicting Diagnostic Accuracy of Cystatin C and Creatinine in Detection of Renal Function among Longstanding Type-2 Diabetics. Journal of Clinical & Diagnostic Research, 15(7), 6-10. https://doi.org/10.7860/JCDR/2021/48764.15091
Pradeepa, R., & Mohan , V. (2021). Epidemiology of type 2 diabetes in India. Indian J Ophthalmol, 69(11), 2932–2938. https://doi.org/10.4103/ijo.IJO_1627_21
Ramírez Lopez, L., Albarracín Suárez, L., Castillo Zaraza, D., Bueno Sánchez, J., & Aguilera Becerra, A. (2019). Cistatina C vs. marcadores convencionales de función renal: una actualización. Revista Salud Uninorte, 35(1), 110-132. http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-55522019000100110&lng=en&tlng=es
Razzaq Najjar, Z. S. (2023). An Evaluation of Cystatin C Levels in the Serum and Urine as Early Diagnostic for Iraqi Patients with Type 2 Diabetes. History of Medicine, 9(1). https://doi.org/10.17720/2409-5834
Roden, M., & Shulman, G. (2019). The integrative biology of type 2 diabetes. Nature, 576(7785), 51–60. https://doi.org/10.1038/s41586-019-1797-8
Rosell de la Torre, D., Gil del Valle, L., Herrera Preval, Y., Del Toro García, G., Reyes, A., & Rosell Guerra, T. (2022). LA CISTATINA C: MARCADOR DE UTILIDAD EN EL DAÑO RENAL EN PATOLOGÍAS Y/O POR EL USO DE FÁRMACOS. Revista CENIC Ciencias Biológicas, 53(3), 252-267. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2221-24502022000300252&lng=es&tlng=en
SaleamKhalaf, M. (2021). Evaluation of Serum Cystatin C Level in Patients with Diabetic Nephropathy. Annals of the Romanian Society for Cell Biology, 25(4), 11704-11707. http://annalsofrscb.ro/index.php/journal/article/view/3992
Salman, M. N., Hamzah, A. S., & kzar, A. J. (2022). Determination of Cystatin C Level in a Sample of Patients with Chronic Kidney Disease. Journal of Techniques, 4(33), 7-11. https://doi.org/https://doi.org/10.51173/jt.v4i33.520
Sapkota, S., Khatiwada, S., Shrestha, S., Baral, N., Maskey, R., Majhi, S., Chandra, L., & Lamsal, M. (2021). Diagnostic Accuracy of Serum Cystatin C for Early Recognition of Nephropathy in Type 2 Diabetes Mellitus. International Journal of Nephrology, 2021, 7. https://doi.org/10.1155/2021/8884126
Sapra, A., & Bhandari, P. (2023). Diabetes. Retrieved 14 de Septiembre de 2023, from Diabetes: https://www.ncbi.nlm.nih.gov/books/NBK551501/
Siddiqui, S. S. (2020). Serum Cystatin C in Early Identification of Acute Kidney Injury in Acute Pancreatitis: Is It an Old Wine in a New Bottle? Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine, 24(9), 744. https://doi.org/10.5005/jp-journals-10071-23579
Sugahara, M., Will Pak, W. L., Tanaka, T., W Tang, S. C., & Nangaku , M. (2021). Update on diagnosis, pathophysiology, and management of diabetic kidney disease. Nephrology (Carlton), 26(6), 491-500. https://doi.org/https://doi.org/10.1111/nep.13860
Taha, M. M., Mahdy-Abdallah , H., Shahy, E. M., Helmy, M. A., & ElLaithy, L. S. (2023). Diagnostic efficacy of cystatin-c in association with different ACE genes predicting renal insufficiency in T2DM. Sci Rep, 13(1), 5288. https://doi.org/https://doi.org/10.1038/s41598-023-32012-w
Taher, A. Y., Alsodani, M. H., & El-Yassin, H. D. (2022). Assessment of correlation between serum βTP and cystatin C as biomarkers for the detection of early nephropathy in Iraqi patients with type 2 diabetes. diabetes, 6(S5), 7774–7784. https://doi.org/https://doi.org/10.53730/ijhs.v6nS5.10544
Torres, I., Sippy, R., Bardosh, K. L., Bhargava, R., Lotto-Batista, M., Bideaux, A. E., Garcia-Trabanino, R., Goldsmith, A., Narsipur, S. S., & Stewart-Ibarra, A. M. (2022). Chronic kidney disease in Ecuador: An epidemiological and health system analysis of an emerging public health crisis. Plos One, 17(3), e0265395. https://doi.org/https://doi.org/10.1371/journal.pone.0265395
Urbina Aucancela, C. Y., & Urbina Aucancela, K. D. (2021). Cistatina C y Creatinina Sérica como predictor de falla renal aguda en pacientes críticamente enfermo. Revista Cientifica Mundo de la Investigación y el Conocimiento, 5(4), 132-142. https://doi.org/https://doi.org/10.26820/recimundo/5.(4).oct.2021.132-142
Vigan, J., Ahoui, S., Agboton, B. L., Sabi, K. A., Tia, W. M., Tchaba, F. R., & Djrolo, F. (2019). Assessment of serum cystatin C in the early detection of type 2 diabetic nephropathy in Cotonou, Benin. African Journal of Nephrology, 22(1), 17-20. https://doi.org/https://doi.org/10.21804/22-1-2541
Wang, S., & Yan, X. (2020). The value of serum cystatin C combined with mir-16-5p in the early diagnosis of diabetic kidney disease (DKD). ACTA MEDICA MEDITERRANEA, 36(3), 1581-1585. https://doi.org/10.19193/0393-6384_2020_3_247
Wang, Y. S., Ye, J., Yang, X., Zhang, G. P., Cao, Y. H., Zhang, R., Dai , W., & Zhang , Q. (2019). Association of retinol binding protein-4, cystatin C, homocysteine and high-sensitivity C-reactive protein levels in patients with newly diagnosed type 2 diabetes mellitus. Arch Med Sci, 15(5), 1203-1216. https://doi.org/10.5114/aoms.2018.79565
Wei, J., Wang, B., Shen, F. J., Zhang, T. T., Duan, Z., & Zhou, D. M. (2022). Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy. BMC Nephrol, 23(1), 270. https://doi.org/10.1186/s12882-022-02888-3
Xinyan, Z. (2021). Study on related indexes of peripheral blood and urine in early diabetic nephropathy in middle-aged and elderly patients. J Clin Hematol, 34(8), 564-567. https://doi.org/10.13201/j.issn.1004-2806.2021.08.009
Xu, W., Tang, S., Xiang, M., & Peng, J. (2019). Serum Homocysteine, cystatin C as biomarkers for progression of diabetic nephropathy. Pteridines, 30(1), 183-188. https://doi.org/https://doi.org/10.1515/pteridines-2019-0024
Yahya, A. A., Kadhim, D. J., & Abdalhadi, N. A. (2022). Kidney injury molecule-1 and cystatin C as early biomarkers for renal dysfunction in Iraqi type 2 diabetes mellitus patients. International Journal of Health Sciences, 6(5), 7774–7784. https://doi.org/https://doi.org/10.5455/jabet.2023.d158
Żyłka, A., Dumnicka, P., Kuśnierz-Cabala, B., Gala-Błądzińska, A., Ceranowicz, P., Kucharz, J., Ząbek-Adamska, A., Maziarz, B., Drożdż, R., & Kuźniewski8, M. (2018). Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients. Mediators of inflammation, 2018, 12. https://doi.org/10.1155/2018/7659243
Publicado
Cómo citar
Número
Sección
Categorías
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
®
Los autores se comprometen a respetar la información académica de otros autores, y a ceder los derechos de autor a la Revista MQRInvestigar, para que el artículo pueda ser editado, publicado y distribuido. El contenido de los artículos científicos y de las publicaciones que aparecen en la revista es responsabilidad exclusiva de sus autores. La distribución de los artículos publicados se realiza bajo una licencia 
